ScoreWhy is Anthem Biosciences Ltd ?
1
With ROE of 17.7, it has a Very Expensive valuation with a 15.4 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 35%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.80%
EBIT Growth (5y)
44.32%
EBIT to Interest (avg)
56.77
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.62
Tax Ratio
28.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.83%
ROCE (avg)
32.59%
ROE (avg)
19.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
88
Industry P/E
35
Price to Book Value
15.43
EV to EBIT
70.47
EV to EBITDA
62.50
EV to Capital Employed
22.96
EV to Sales
23.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
32.59%
ROE (Latest)
17.74%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
NET SALES(Q)
Highest at Rs 610.94 cr
PBDIT(Q)
Highest at Rs 267.21 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 43.74%
PBT LESS OI(Q)
Highest at Rs 225.73 cr.
PAT(Q)
Highest at Rs 189.09 cr.
EPS(Q)
Highest at Rs 3.38
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Anthem Bioscienc
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 225.73 cr has Grown at 43.0% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 157.84 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 189.09 cr has Grown at 50.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 125.68 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 610.94 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 610.94 cr has Grown at 22.4% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 499.15 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 267.21 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 43.74%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 225.73 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 189.09 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 3.38
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Anthem Bioscienc
Non Operating Income - Quarterly
Highest at Rs 51.21 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
